Literature DB >> 21455700

Efficiency improvement in a class of survival models through model-free covariate incorporation.

Tanya P Garcia1, Yanyuan Ma, Guosheng Yin.   

Abstract

In randomized clinical trials, we are often concerned with comparing two-sample survival data. Although the log-rank test is usually suitable for this purpose, it may result in substantial power loss when the two groups have nonproportional hazards. In a more general class of survival models of Yang and Prentice (Biometrika 92:1-17, 2005), which includes the log-rank test as a special case, we improve model efficiency by incorporating auxiliary covariates that are correlated with the survival times. In a model-free form, we augment the estimating equation with auxiliary covariates, and establish the efficiency improvement using the semiparametric theories in Zhang et al. (Biometrics 64:707-715, 2008) and Lu and Tsiatis (Biometrics, 95:674-679, 2008). Under minimal assumptions, our approach produces an unbiased, asymptotically normal estimator with additional efficiency gain. Simulation studies and an application to a leukemia study show the satisfactory performance of the proposed method. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455700     DOI: 10.1007/s10985-011-9195-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  12 in total

1.  Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.

Authors:  C M Tangen; G G Koch
Journal:  J Biopharm Stat       Date:  1999-05       Impact factor: 1.051

2.  A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.

Authors:  Emmanuel Lesaffre; Stephen Senn
Journal:  Stat Med       Date:  2003-12-15       Impact factor: 2.373

3.  Analysis of survival data with cross-effects of survival functions.

Authors:  Vilijandas Bagdonavicius; Mohamed A Hafdi; Mikhail Nikulin
Journal:  Biostatistics       Date:  2004-07       Impact factor: 5.899

4.  Adjustment for baseline covariates: an introductory note.

Authors:  Jean-Marie Grouin; Simon Day; John Lewis
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

Review 5.  Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Authors:  W W Hauck; S Anderson; S M Marcus
Journal:  Control Clin Trials       Date:  1998-06

Review 6.  Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.

Authors:  G G Koch; C M Tangen; J W Jung; I A Amara
Journal:  Stat Med       Date:  1998 Aug 15-30       Impact factor: 2.373

7.  Time-dependent effects of fixed covariates in Cox regression.

Authors:  P J Verweij; H C van Houwelingen
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

8.  Analysis of survival data by the proportional odds model.

Authors:  S Bennett
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

9.  Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions.

Authors:  K R Hess
Journal:  Stat Med       Date:  1994-05-30       Impact factor: 2.373

10.  Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.

Authors:  Min Zhang; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrics       Date:  2008-01-11       Impact factor: 1.701

View more
  4 in total

1.  Evaluating surrogate marker information using censored data.

Authors:  Layla Parast; Tianxi Cai; Lu Tian
Journal:  Stat Med       Date:  2017-01-15       Impact factor: 2.373

2.  Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Authors:  Song Yang; Ross L Prentice
Journal:  Stat Med       Date:  2015-02-17       Impact factor: 2.373

3.  Landmark estimation of survival and treatment effects in observational studies.

Authors:  Layla Parast; Beth Ann Griffin
Journal:  Lifetime Data Anal       Date:  2016-02-15       Impact factor: 1.588

4.  Quantifying the feasibility of shortening clinical trial duration using surrogate markers.

Authors:  Xuan Wang; Tianxi Cai; Lu Tian; Florence Bourgeois; Layla Parast
Journal:  Stat Med       Date:  2021-09-02       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.